Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A22614 | 24412604 | J Hepatol | MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury. | 2014 | Details |
| A22625 | 24401715 | Am J Clin Nutr | Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. | 2014 | Details |
| A22631 | 24396649 | Endocrinol Metab (Seoul) | Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study. | 2013 | Details |
| A22634 | 24393106 | Antioxid Redox Signal | Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin. | 2014 | Details |
| A22642 | 24388885 | J Physiol Pharmacol | Apolipoprotein E4 allele is associated with substantial changes in the plasma lipids and hyaluronic acid content in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A22643 | 24388027 | Mayo Clin Proc | Drug-induced liver injury. | 2014 | Details |
| A22655 | 24379011 | Nutrients | Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention. | 2013 | Details |
| A22661 | 24377455 | Nutrition | Effects of bayberry juice on inflammatory and apoptotic markers in young adults with features of non-alcoholic fatty liver disease. | 2014 | Details |
| A22678 | 26528002 | Clujul Med | From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome? | 2014 | Details |
| A22703 | 25744638 | Nihon Rinsho Meneki Gakkai Kaishi | [Cellular senescence and chronic inflammation]. | 2014 | Details |
| A22706 | 24367597 | PLoS One | Therapy of experimental NASH and fibrosis with galectin inhibitors. | 2013 | Details |
| A22712 | 24363521 | World J Gastroenterol | Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders. | 2013 | Details |
| A22723 | 24356885 | Am J Physiol Gastrointest Liver Physiol | Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease. | 2013 | Details |
| A22730 | 24351808 | Int J Mol Sci | EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD. | 2013 | Details |
| A22732 | 24349208 | PLoS One | Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans. | 2013 | Details |
| A22757 | 24327268 | Hepatology | Hepatocyte-specific Ptpn6 deletion promotes hepatic lipid accretion, but reduces NAFLD in diet-induced obesity: potential role of PPARγ. | 2014 | Details |
| A22758 | 24326630 | Dig Dis Sci | Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride. | 2013 | Details |
| A22761 | 24325457 | J Med Food | The effects of α-lipoic acid on liver oxidative stress and free fatty acid composition in methionine-choline deficient diet-induced NAFLD. | 2013 | Details |
| A22763 | 24324749 | PLoS One | Cytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis. | 2013 | Details |
| A22768 | 24321532 | J Pediatr | Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A22771 | 24320032 | Curr Pharm Des | The metabolic syndrome and chronic liver disease. | 2014 | Details |
| A22778 | 24314869 | J Nutr Biochem | Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet. | 2013 | Details |
| A22781 | 24312613 | PLoS One | Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death. | 2013 | Details |
| A22792 | 24302567 | Mol Nutr Food Res | Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds. | 2013 | Details |
| A22795 | 24299564 | Hepatol Res | Abnormality of autophagic function and cathepsin expression in the liver from patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22799 | 24295779 | Biochim Biophys Acta | Omega-3 phospholipids from fish suppress hepatic steatosis by integrated inhibition of biosynthetic pathways in dietary obese mice. | 2014 | Details |
| A22808 | 26355775 | J Clin Transl Hepatol | Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention. | 2013 | Details |
| A22811 | 26202294 | Hepatol Int | An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis. | 2013 | Details |
| A22813 | 26202292 | Hepatol Int | Current histological classification of NAFLD: strength and limitations. | 2013 | Details |
| A22818 | 24298175 | Clin Med (Lond) | Repair-associated inflammation in nonalcoholic fatty liver disease. | 2013 | Details |
| A22821 | 24285955 | Int J Endocrinol | Multidisciplinary approach to the treatment of obese adolescents: effects on cardiovascular risk factors, inflammatory profile, and neuroendocrine regulation of energy balance. | 2013 | Details |
| A22826 | 24280560 | Med Hypotheses | Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction. | 2013 | Details |
| A22833 | 24275089 | Food Chem Toxicol | Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. | 2013 | Details |
| A22843 | 24274869 | Clin Liver Dis | Surgical management of obesity in patients with morbid obesity and nonalcoholic fatty liver disease. | 2013 | Details |
| A22876 | 24260182 | PLoS One | The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. | 2013 | Details |
| A22878 | 24259964 | World J Gastroenterol | Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver. | 2013 | Details |
| A22883 | 24256086 | Am J Respir Crit Care Med | Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance. | 2014 | Details |
| A22885 | 24254368 | Hepatology | The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. | 2014 | Details |
| A22891 | 24249635 | FASEB J | Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. | 2013 | Details |
| A22898 | 24226095 | J Biol Chem | Retinoic acid-related orphan receptor α regulates diurnal rhythm and fasting induction of sterol 12α-hydroxylase in bile acid synthesis. | 2013 | Details |
| A22899 | 24224789 | Acta Physiol (Oxf) | Maternal western diet primes non-alcoholic fatty liver disease in adult mouse offspring. | 2014 | Details |
| A22911 | 24219909 | Cell Signal | Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. | 2013 | Details |
| A22916 | 24214843 | Mol Nutr Food Res | Genistein alleviates the development of nonalcoholic steatohepatitis in ApoE(-/-) mice fed a high-fat diet. | 2013 | Details |
| A22924 | 24206551 | Rev Esp Enferm Dig | Pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease. | 2013 | Details |
| A22929 | 24199670 | J Gastroenterol Hepatol | Coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection? | 2014 | Details |
| A22936 | 24192824 | Int J Mol Sci | Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. | 2013 | Details |
| A22937 | 24192698 | Pediatr Res | Developmental origins of nonalcoholic fatty liver disease. | 2013 | Details |
| A22939 | 24190226 | Int J Mol Med | Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats. | 2013 | Details |
| A22947 | 24187449 | World J Gastroenterol | Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease. | 2013 | Details |
| A22971 | 24157968 | Am J Physiol Gastrointest Liver Physiol | Purinergic receptor X7 is a key modulator of metabolic oxidative stress-mediated autophagy and inflammation in experimental nonalcoholic steatohepatitis. | 2013 | Details |
| A22983 | 24134913 | Biochem Pharmacol | Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1/sphingosine 1-phosphate signaling pathway. | 2013 | Details |
| A22995 | 24130212 | Hum Exp Toxicol | Dynamics of oxidative/nitrosative stress in mice with methionine-choline-deficient diet-induced nonalcoholic fatty liver disease. | 2013 | Details |
| A22996 | 24129399 | Am J Physiol Endocrinol Metab | Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet. | 2013 | Details |
| A23006 | 24119413 | BMC Complement Altern Med | Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease. | 2013 | Details |
| A23009 | 24118921 | Hepatol Res | Hepatic molecular effects of rosiglitazone in human non-alcoholic steatohepatitis suggest long-term pro-inflammatory damage. | 2013 | Details |
| A23016 | 24115128 | Hepatology | Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. | 2014 | Details |
| A23022 | 24107103 | Liver Int | Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype. | 2013 | Details |
| A23036 | 24086498 | PLoS One | Coordinated and interactive expression of genes of lipid metabolism and inflammation in adipose tissue and liver during metabolic overload. | 2013 | Details |
| A23037 | 24084730 | Int J Mol Sci | Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis. | 2013 | Details |
| A23040 | 24084392 | J Chin Med Assoc | The involvement of NLRX1 and NLRP3 in the development of nonalcoholic steatohepatitis in mice. | 2013 | Details |
| A23054 | 24074715 | Zhonghua Gan Zang Bing Za Zhi | [Non-canonical Wnt signaling contributes to development of non-alcoholic steatohepatitis in a rat model of type 2 diabetes mellitus]. | 2013 | Details |
| A23059 | 24073298 | World J Hepatol | Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease. | 2013 | Details |
| A23070 | 24066058 | PLoS One | Aldose reductase is involved in the development of murine diet-induced nonalcoholic steatohepatitis. | 2013 | Details |
| A23076 | 24064383 | Free Radic Biol Med | CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis. | 2013 | Details |
| A23077 | 24064253 | Clin Nutr | Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. | 2013 | Details |
| A23089 | 24048504 | Med Mol Morphol | Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis. | 2013 | Details |
| A23094 | 24044579 | Lipids Health Dis | Age-dependent effect of high-fructose and high-fat diets on lipid metabolism and lipid accumulation in liver and kidney of rats. | 2013 | Details |
| A23103 | 24039933 | PLoS One | Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation. | 2013 | Details |
| A23104 | 24039859 | PLoS One | Hepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalchoholic fatty liver disease. | 2013 | Details |
| A23112 | 24033085 | Eur J Clin Invest | Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis. | 2013 | Details |
| A23113 | 24030232 | Dig Dis | Liver complications in inflammatory bowel diseases. | 2013 | Details |
| A23130 | 24018165 | Semin Cancer Biol | Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease. | 2013 | Details |
| A23131 | 24018052 | Gastroenterology | Therapeutic potential of fecal microbiota transplantation. | 2013 | Details |
| A23144 | 24006666 | Zhen Ci Yan Jiu | [Influence of electroacupuncture stimulation on serum and hepatic interleukin-18 expression in nonalcoholic fatty liver rats]. | 2013 | Details |
| A23150 | 24002947 | Hepatology | Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia. | 2014 | Details |
| A23153 | 24000796 | Free Radic Res | Oxysterols and redox signaling in the pathogenesis of non-alcoholic fatty liver disease. | 2013 | Details |
| A23161 | 23996518 | Horm Metab Res | Olive oil attenuates the cholesterol-induced development of nonalcoholic steatohepatitis despite increased insulin resistance in a rodent model. | 2013 | Details |
| A23168 | 23988487 | Biochem Pharmacol | Bile acid receptors in non-alcoholic fatty liver disease. | 2013 | Details |
| A23178 | 23982157 | Am J Physiol Endocrinol Metab | Intracellular lipid content is a key intrinsic determinant for hepatocyte viability and metabolic and inflammatory states in mice. | 2013 | Details |
| A23192 | 23973920 | Gastroenterology | Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis. | 2013 | Details |
| A23199 | 23966104 | Thromb Haemost | The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. | 2013 | Details |
| A23200 | 23965360 | Endocr J | Rosiglitazone attenuates casein-induced hepatic endoplasmic reticulum stress in Sprague-Dawley rats: a novel model of endoplasmic reticulum stress. | 2013 | Details |
| A23201 | 23964925 | Genet Test Mol Biomarkers | Association of nicotinamide-N-methyltransferase gene rs694539 variant with patients with nonalcoholic steatohepatitis. | 2013 | Details |
| A23218 | 23948064 | Biochem Pharmacol | Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A. | 2013 | Details |
| A23228 | 23939604 | Am Fam Physician | Nonalcoholic fatty liver disease: diagnosis and management. | 2013 | Details |
| A23236 | 23933265 | J Hepatol | Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients. | 2013 | Details |
| A23237 | 23932906 | Clin Gastroenterol Hepatol | The impact of network medicine in gastroenterology and hepatology. | 2013 | Details |
| A23247 | 23928404 | J Hepatol | Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity. | 2013 | Details |
| A23249 | 23928105 | Metabolism | Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. | 2013 | Details |
| A23252 | 23924495 | Hepatobiliary Pancreat Dis Int | Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C. | 2013 | Details |
| A23258 | 23922466 | World J Gastroenterol | Garcinia Cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation. | 2013 | Details |
| A23273 | 23909258 | Vnitr Lek | [Effects of GLP-1 (glucagon-like peptide 1) on liver]. | 2013 | Details |
| A23274 | 23909257 | Vnitr Lek | [Liver disorders in diabetic patients]. | 2013 | Details |
| A23277 | 23905917 | J Allergy Clin Immunol | Innate sensors of pathogen and stress: linking inflammation to obesity. | 2013 | Details |
| A23308 | 23876851 | Semin Cancer Biol | Obesity, insulin resistance, NASH and hepatocellular carcinoma. | 2013 | Details |
| A23309 | 23875831 | BMC Gastroenterol | The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis. | 2013 | Details |
| A23319 | 23873346 | Curr Opin Clin Nutr Metab Care | The gut-liver axis. | 2013 | Details |
| A23324 | 23870449 | BMC Pediatr | Pediatric non alcoholic fatty liver disease: more on novel treatment targets. | 2013 | Details |
| A23334 | 23862644 | Annu Rev Nutr | Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease. | 2013 | Details |
| A23335 | 23861927 | PLoS One | Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet. | 2013 | Details |